LICHEN SIMPLEX CHRONICUS
Clinical trials for LICHEN SIMPLEX CHRONICUS explained in plain language.
Never miss a new study
Get alerted when new LICHEN SIMPLEX CHRONICUS trials appear
Sign up with your email to follow new studies for LICHEN SIMPLEX CHRONICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a CBD cream soothe Eczema's relentless itch?
Disease control ENROLLING_BY_INVITATIONThis phase 2 trial is testing whether a 5% cannabidiol (CBD) cream can reduce itching and skin severity in adults with chronic eczema conditions like atopic dermatitis and nummular eczema. About 60 participants will apply the CBD cream or a standard steroid cream for 4 weeks. The…
Matched conditions: LICHEN SIMPLEX CHRONICUS
Phase: PHASE2 • Sponsor: Khon Kaen University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can an eczema drug stop the itch of lichen simplex chronicus?
Symptom relief OngoingThis Phase 3 trial tests whether dupilumab (Dupixent) can reduce severe itching in adults with lichen simplex chronicus, a skin condition causing intense itch. 142 participants will receive either dupilumab or placebo injections for 24 weeks. The main goal is to see if more peopl…
Matched conditions: LICHEN SIMPLEX CHRONICUS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can an eczema drug stop the relentless itch of lichen simplex chronicus?
Symptom relief OngoingThis Phase 3 trial tests whether dupilumab (Dupixent) injections can reduce severe itching in adults with lichen simplex chronicus, a skin condition causing intense, persistent itch. About 138 participants will receive either dupilumab or a placebo for 24 weeks. The main goal is …
Matched conditions: LICHEN SIMPLEX CHRONICUS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC